These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28829659)

  • 21. Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis.
    Zhang B; Zhu F; Ma X; Tian Y; Cao D; Luo S; Xuan Y; Liu L; Wei Y
    Radiother Oncol; 2014 Aug; 112(2):250-5. PubMed ID: 25236716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.
    Varlotto J; Fakiris A; Flickinger J; Medford-Davis L; Liss A; Shelkey J; Belani C; DeLuca J; Recht A; Maheshwari N; Barriger R; Yao N; DeCamp M
    Cancer; 2013 Aug; 119(15):2683-91. PubMed ID: 23605504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry.
    Yun J; Cho JH; Hong TH; Yang K; Ahn YC; Kim HK; ;
    Cancer Res Treat; 2023 Oct; 55(4):1171-1180. PubMed ID: 37080606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage surgery for local recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: a systematic review.
    Dickhoff C; Rodriguez Schaap PM; Otten RHJ; Heymans MW; Heineman DJ; Dahele M
    Ther Adv Med Oncol; 2018; 10():1758835918787989. PubMed ID: 30023008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognositc significance of SUV
    Dong M; Liu J; Sun X; Xing L
    J Med Imaging Radiat Oncol; 2017 Oct; 61(5):652-659. PubMed ID: 28266166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer.
    Alcibar OL; Nadal E; Romero Palomar I; Navarro-Martin A
    Transl Lung Cancer Res; 2021 Jan; 10(1):529-538. PubMed ID: 33569334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.
    Raghavan G; Shaverdian N; Chan S; Chu FI; Lee P
    Clin Lung Cancer; 2018 Sep; 19(5):e759-e766. PubMed ID: 29954680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer.
    Amin SA; Alam M; Baine MJ; Meza JL; Bennion NR; Zhang C; Rahman I; Lin C
    Radiother Oncol; 2021 Feb; 155():254-260. PubMed ID: 33317997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.
    Ricardi U; Frezza G; Filippi AR; Badellino S; Levis M; Navarria P; Salvi F; Marcenaro M; Trovò M; Guarneri A; Corvò R; Scorsetti M
    Lung Cancer; 2014 Jun; 84(3):248-53. PubMed ID: 24681279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis.
    Viani GA; Gouveia AG; Louie AV; Arcidiacono F; Simone CB; Tsakiridis T; Carolina Hamamura A; Anselmo P; Moraes FY
    Radiother Oncol; 2024 Dec; 201():110439. PubMed ID: 39032835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC.
    Moreno AC; Fellman B; Hobbs BP; Liao Z; Gomez DR; Chen A; Hahn SM; Chang JY; Lin SH
    J Thorac Oncol; 2020 Jan; 15(1):101-109. PubMed ID: 31479748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.
    Rusthoven CG; Kavanagh BD; Karam SD
    Ann Transl Med; 2015 Jul; 3(11):149. PubMed ID: 26244136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
    Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH
    Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
    Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
    Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience.
    Hobbs CJ; Ko SJ; Paryani NN; Accurso JM; Olivier KR; Garces YI; Park SS; Hallemeier CL; Schild SE; Vora SA; Ashman JB; Rule WG; Bowers JR; Heckman MG; Diehl NN; Miller RC
    Mayo Clin Proc Innov Qual Outcomes; 2018 Mar; 2(1):40-48. PubMed ID: 30225431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
    Watanabe K; Katsui K; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    Radiat Oncol; 2021 Feb; 16(1):39. PubMed ID: 33622369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies.
    Viani GA; Gouveia AG; Yan M; Matsuura FK; Moraes FY
    J Bras Pneumol; 2022; 48(3):e20210390. PubMed ID: 35508065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.
    Simone CB; Dorsey JF
    Ann Transl Med; 2015 Aug; 3(13):172. PubMed ID: 26366389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.